VolitionRx Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2010
Net Income	-34.91	-35.32	-30.27	-26.81	-20.35	-16.1	Upgrade
Depreciation & Amortization	1.4	1.41	1.19	1.15	1.04	0.9	Upgrade
Share-Based Compensation	2.01	2.29	3.11	5.12	1.73	1.47	Upgrade
Other Operating Activities	13.84	13.55	10.69	-0.31	1.12	0.99	Upgrade
Operating Cash Flow	-17.66	-18.06	-15.28	-20.85	-16.46	-12.74	Upgrade
Capital Expenditures	-0.91	-1.08	-1.57	-0.97	-1.65	-0.51	Upgrade
Other Investing Activities	-0.05	-	-	-	-	-	Upgrade
Investing Cash Flow	-0.96	-1.08	-1.57	-0.97	-1.65	-0.51	Upgrade
Share Issuance / Repurchase	19.98	28.36	6.74	23.22	21.14	16.59	Upgrade
Debt Issued / Paid	0.84	0.83	0.21	-0.22	-0.3	0.34	Upgrade
Other Financing Activities	-0.19	-0.2	-0.01	-0.14	-0.22	-0.01	Upgrade
Financing Cash Flow	20.63	28.98	6.94	22.86	20.62	16.93	Upgrade
Exchange Rate Effect	-0.24	0.03	0.2	0.11	-0.03	-0.14	Upgrade
Net Cash Flow	1.76	9.86	-9.71	1.14	2.48	3.54	Upgrade
Free Cash Flow	-18.57	-19.15	-16.85	-21.83	-18.11	-13.25	Upgrade
Free Cash Flow Margin	-2330.23%	-2469.59%	-5498.81%	-24243.33%	-134832.07%	-77507.73%	Upgrade
Free Cash Flow Per Share	-0.23	-0.27	-0.30	-0.41	-0.40	-0.34	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).